NT157

CAT: 0804-HY-100037-01Size: 2 mgDry Ice: NoHazardous: No
CAT#:0804-HY-100037-01Size:2 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
NT157 (Tyrphostin NT157) is a selective IRS-1/2 inhibitor that induces Ser-phosphorylation and consequently the degradation of IRS-1/2. NT157 (Tyrphostin NT157) is a first-in-class anti-cancer agent that also targets Stat3 signaling pathway[1][2].
CAS Number
[1384426-12-3]
Product Name Alternative
Tyrphostin NT157
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Insulin Receptor; STAT
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/NT157.html
Purity
99.38
Solubility
DMSO : ≥ 30 mg/mL
Smiles
S=C(NCC1=CC(O)=C(O)C(O)=C1)/C=C/C2=CC(O)=C(O)C(Br)=C2
Molecular Formula
C16H14BrNO5S
Molecular Weight
412.26
Precautions
H302, H315, H319, H335
References & Citations
[1]Downregulated the Tyr-phosphorylation of IRS-1 in the MG-63 and U-2OS cells.|[2]Flashner-Abramson E, et al. Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling. Oncogene. 2016 May 19;35 (20) :2675-80.|[3]Ibuki N, et al. The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer. Mol Cancer Ther. 2014 Dec;13 (12) :2827-39.|[4]Ishii H, et al. miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity. Nat Commun. 2018 Jul 4;9 (1) :2611.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName

Popular Products